Home One year B-vitamins increases serum and whole blood folate forms and lowers plasma homocysteine in older Germans
Article
Licensed
Unlicensed Requires Authentication

One year B-vitamins increases serum and whole blood folate forms and lowers plasma homocysteine in older Germans

  • Susanne H. Kirsch , Wolfgang Herrmann , Vera Kruse , Rudolf Eckert , Stefan Gräber , Jürgen Geisel and Rima Obeid EMAIL logo
Published/Copyright: October 6, 2014

Abstract

Background: We aimed to study the effect of long-term supplementation of B-vitamins on folate forms in serum and whole blood (WB) in elderly German subjects.

Methods: 59 participants (mean age 67 years) were randomized to daily receive either vitamin D3 (1200 IU), folic acid (500 μg), vitamin B12 (500 μg), vitamin B6 (50 mg), and calcium carbonate (456 mg) or vitamin D3 plus calcium carbonate. Serum and WB folate forms were measured before and after 6 and 12 months.

Results: B-vitamins supplementation for 6 months led to higher concentrations of 5-methyltetrahydrofolate (5-methylTHF) in serum (mean 49.1 vs. 19.6 nmol/L) and WB (1332 vs. 616 nmol/L). Also non-methyl-folate concentrations in serum and WB were higher after 6 months with B-vitamins supplementation. Unmetabolized folic acid (UFA) increased after supplementation. tHcy concentration was lowered after 1 year of B-vitamin supplementation (mean 13.1 vs. 9.6 μmol/L). A stronger reduction of tHcy after 1 year was found in participants who had baseline level >12.5 μmol/L (mean 17.0 vs. 11.9 μmol/L) compared to those with baseline tHcy lower than this limit (mean 9.1 vs. 7.4 μmol/L). In contrast, the increases in serum and WB 5-methylTHF were comparable between the two groups.

Conclusions: One year B-vitamins supplementation increased the levels of 5-methylTHF and non-methyl-folate in serum and WB, normalized tHcy, but caused an increase in the number of cases with detectable UFA in serum. Lowering of tHcy was predicted by baseline tHcy, but not by baseline serum or WB 5-methylTHF.


Corresponding author: Prof. Dr. Rima Obeid, Department of Clinical Chemistry and Laboratory Medicine, Saarland University Hospital, Building 57, 66421 Homburg/Saar, Germany, Phone: +49 8411630711, Fax: +49 8411630703, E-mail:

References

1. Pfeiffer CM, Fazili Z, McCoy L, Zhang M, Gunter EW. Determination of folate vitamers in human serum by stable-isotope-dilution tandem mass spectrometry and comparison with radioassay and microbiologic assay. Clin Chem 2004;50:423–32.10.1373/clinchem.2003.026955Search in Google Scholar PubMed

2. Wagner C, Koury MJ. S-Adenosylhomocysteine: a better indicator of vascular disease than homocysteine? Am J Clin Nutr 2007;86:1581–5.10.1093/ajcn/86.5.1581Search in Google Scholar PubMed

3. Shannon J, Phoutrides E, Palma A, Farris P, Peters L, Forester A, et al. Folate intake and prostate cancer risk: a case-control study. Nutr Cancer 2009;61:617–28.10.1080/01635580902846593Search in Google Scholar PubMed

4. Obeid R, Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 2006;580:2994–3005.10.1016/j.febslet.2006.04.088Search in Google Scholar PubMed

5. Malouf R, Grimley EJ. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev 2008;CD004514.10.1002/14651858.CD004514.pub2Search in Google Scholar PubMed

6. Herrmann W, Obeid R. Homocysteine: a biomarker in neurodegenerative diseases. Clin Chem Lab Med 2011;49:435–41.10.1515/CCLM.2011.084Search in Google Scholar PubMed

7. Clarke R, Grimley EJ, Schneede J, Nexo E, Bates C, Fletcher A, et al. Vitamin B12 and folate deficiency in later life. Age Ageing 2004;33:34–41.10.1093/ageing/afg109Search in Google Scholar PubMed

8. Gregory JF III. Case study: folate bioavailability. J Nutr 2001;131:1376S–82S.10.1093/jn/131.4.1376SSearch in Google Scholar PubMed

9. McKillop DJ, McNulty H, Scott JM, McPartlin JM, Strain JJ, Bradbury I, et al. The rate of intestinal absorption of natural food folates is not related to the extent of folate conjugation. Am J Clin Nutr 2006;84:167–73.10.1093/ajcn/84.1.167Search in Google Scholar PubMed

10. Shane B, Stokstad EL. Vitamin B12-folate interrelationships. Annu Rev Nutr 1985;5:115–41.10.1146/annurev.nu.05.070185.000555Search in Google Scholar PubMed

11. Kirsch SH, Herrmann W, Eckert R, Geisel J, Obeid R. Factors affecting the distribution of folate forms in the serum of elderly German adults. Eur J Nutr 2013;52:497–504.10.1007/s00394-012-0351-3Search in Google Scholar PubMed

12. Tucker KL, Mahnken B, Wilson PW, Jacques P, Selhub J. Folic acid fortification of the food supply. Potential benefits and risks for the elderly population. J Am Med Assoc 1996;276:1879–85.10.1001/jama.1996.03540230029031Search in Google Scholar PubMed

13. de Bree A, Verschuren WM, Blom HJ, Kromhout D. Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20–65 y. Am J Clin Nutr 2001;73:1027–33.10.1093/ajcn/73.6.1027Search in Google Scholar PubMed

14. Young PJ, Nicolas G, Freisling H, Biessy C, Scalbert A, Romieu I, et al. Comparison of standardised dietary folate intake across ten countries participating in the European Prospective Investigation into Cancer and Nutrition. Br J Nutr 2012;108:552–69.10.1017/S0007114511005733Search in Google Scholar PubMed

15. Baker PN, Wheeler SJ, Sanders TA, Thomas JE, Hutchinson CJ, Clarke K, et al. A prospective study of micronutrient status in adolescent pregnancy. Am J Clin Nutr 2009;89:1114–24.10.3945/ajcn.2008.27097Search in Google Scholar PubMed

16. Czeizel AE, Susanszky E. Diet intake and vitamin supplement use of Hungarian women during the preconceptional period. Int J Vitam Nutr Res 1994;64:300–5.Search in Google Scholar

17. Krawinkel MB, Strohm D, Weissenborn A, Watzl B, Eichholzer M, Bärlocher K, Elmadfa I, Leschik-Bonnet E, Heseker H. Revised D-A-CH intake recommendations for folate: how much is needed? Eur J Clin Nutr 2014;68:719–23.10.1038/ejcn.2014.45Search in Google Scholar PubMed PubMed Central

18. Boilson A, Staines A, Kelleher CC, Daly L, Shirley I, Shrivastava A, et al. Unmetabolized folic acid prevalence is widespread in the older Irish population despite the lack of a mandatory fortification program. Am J Clin Nutr 2012;96:613–21.10.3945/ajcn.111.026633Search in Google Scholar PubMed

19. Kelly P, McPartlin J, Goggins M, Weir DG, Scott JM. Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr 1997;65:1790–5.10.1093/ajcn/65.6.1790Search in Google Scholar PubMed

20. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniors. Am J Clin Nutr 2010;91:1733–44.10.3945/ajcn.2009.28671Search in Google Scholar PubMed

21. Lucock M. Is folic acid the ultimate functional food component for disease prevention? Br Med J 2004;328:211–4.10.1136/bmj.328.7433.211Search in Google Scholar PubMed PubMed Central

22. Herrmann W, Kirsch SH, Kruse V, Eckert R, Graber S, Geisel J, et al. One year B and D vitamins supplementation improves metabolic bone markers. Clin Chem Lab Med 2013;51:639–47.10.1515/cclm-2012-0599Search in Google Scholar

23. Kirsch SH, Knapp JP, Herrmann W, Obeid R. Quantification of key folate forms in serum using stable-isotope dilution ultra performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010;878:68–75.10.1016/j.jchromb.2009.11.021Search in Google Scholar

24. Kirsch SH, Herrmann W, Geisel J, Obeid R. Assay of whole blood (6S)-5-CH(3)-H (4)folate using ultra performance liquid chromatography tandem mass spectrometry. Anal Bioanal Chem 2012;404:895–902.10.1007/s00216-012-6180-7Search in Google Scholar

25. Kalmbach RD, Choumenkovitch SF, Troen AM, D’Agostino R, Jacques PF, Selhub J. Circulating folic acid in plasma: relation to folic acid fortification. Am J Clin Nutr 2008;88:763–8.10.1093/ajcn/88.3.763Search in Google Scholar

26. Tighe P, Ward M, McNulty H, Finnegan O, Dunne A, Strain J, et al. A dose-finding trial of the effect of long-term folic acid intervention: implications for food fortification policy. Am J Clin Nutr 2011;93:11–8.10.3945/ajcn.2010.29427Search in Google Scholar

27. Cuskelly GJ, McNulty H, Scott JM. Fortification with low amounts of folic acid makes a significant difference in folate status in young women: implications for the prevention of neural tube defects. Am J Clin Nutr 1999;70:234–9.10.1093/ajcn.70.2.234Search in Google Scholar

28. Farrell CJ, Kirsch SH, Herrmann M. Red cell or serum folate: what to do in clinical practice? Clin Chem Lab Med 2013;51:555–69.10.1515/cclm-2012-0639Search in Google Scholar

29. Fazili Z, Pfeiffer CM, Zhang M. Comparison of serum folate species analyzed by LC-MS/MS with total folate measured by microbiologic assay and Bio-Rad radioassay. Clin Chem 2007;53:781–4.10.1373/clinchem.2006.078451Search in Google Scholar

30. Summers CM, Mitchell LE, Stanislawska-Sachadyn A, Baido SF, Blair IA, Von Feldt JM, et al. Genetic and lifestyle variables associated with homocysteine concentrations and the distribution of folate derivatives in healthy premenopausal women. Birth Defects Res A Clin Mol Teratol 2010;88:679–88.10.1002/bdra.20683Search in Google Scholar

31. Daly S, Mills JL, Molloy AM, Conley M, Lee YJ, Kirke PN, et al. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet 1997;350:1666–9.10.1016/S0140-6736(97)07247-4Search in Google Scholar

32. Pietrzik K, Lamers Y, Bramswig S, Prinz-Langenohl R. Calculation of red blood cell folate steady state conditions and elimination kinetics after daily supplementation with various folate forms and doses in women of childbearing age. Am J Clin Nutr 2007;86:1414–9.10.1093/ajcn/86.5.1414Search in Google Scholar PubMed

33. Obeid R, Kirsch SH, Kasoha M, Eckert R, Herrmann W. Concentrations of unmetabolized folic acid and primary folate forms in plasma after folic acid treatment in older adults. Metabolism 2011;60:673–8.Search in Google Scholar

34. Huang Y, Khartulyari S, Morales ME, Stanislawska-Sachadyn A, Von Feldt JM, Whitehead AS, et al. Quantification of key red blood cell folates from subjects with defined MTHFR 677C>T genotypes using stable isotope dilution liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 2008;22:2403–12.10.1002/rcm.3624Search in Google Scholar PubMed PubMed Central

35. Hursthouse NA, Gray AR, Miller JC, Rose MC, Houghton LA. Folate status of reproductive age women and neural tube defect risk: the effect of long-term folic acid supplementation at doses of 140 μg and 400 μg per day. Nutrients 2011;3:49–62.10.3390/nu3010049Search in Google Scholar PubMed PubMed Central

Received: 2014-5-22
Accepted: 2014-8-24
Published Online: 2014-10-6
Published in Print: 2015-2-1

©2015 by De Gruyter

Articles in the same Issue

  1. Frontmatter
  2. Editorials
  3. Variable accuracy of home pregnancy tests: truth in advertising?
  4. The highs and lows of tumor biomarkers: lost illusions
  5. Mini Review
  6. Matrix metalloproteinases as biomarkers of disease: updates and new insights
  7. Opinion Papers
  8. Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working group for Preanalytical Phase (WG-PRE)
  9. Colour coding for blood collection tube closures – a call for harmonisation
  10. Harmonization protocols for thyroid stimulating hormone (TSH) immunoassays: different approaches based on the consensus mean value
  11. Genetics and Molecular Diagnostics
  12. Detection of HLA-B*58:01 with TaqMan assay and its association with allopurinol-induced sCADR
  13. General Clinical Chemistry and Laboratory Medicine
  14. Comparison of analytical sensitivity and women’s interpretation of home pregnancy tests
  15. Accuracy of GFR estimating equations combining standardized cystatin C and creatinine assays: a cross-sectional study in Sweden
  16. Immunoassay of thyroid peroxidase autoantibodies: diagnostic performance in automated third generation methods. A multicentre evaluation
  17. Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens
  18. Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots
  19. One year B-vitamins increases serum and whole blood folate forms and lowers plasma homocysteine in older Germans
  20. Role of cerebrospinal fluid biomarkers to predict conversion to dementia in patients with mild cognitive impairment: a clinical cohort study
  21. Reference Values and Biological Variations
  22. Salivary morning androstenedione and 17α-OH progesterone levels in childhood and puberty in patients with classic congenital adrenal hyperplasia
  23. The baseline serum value of α-amylase is a significant predictor of distance running performance
  24. Cancer Diagnostics
  25. Urinary thiosulfate as failed prostate cancer biomarker – an exemplary multicenter re-evaluation study
  26. Clinical utility of determining tumor markers in patients with signs and symptoms of cancer
  27. Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patients
  28. The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer
  29. Cardiovascular Diseases
  30. Predictive value for death and rehospitalization of 30-day postdischarge B-type natriuretic peptide (BNP) in elderly patients with heart failure. Sub-analysis of Italian RED Study
  31. Letters to the Editors
  32. Pre-analytical stability of 25(OH)-vitamin D in primary collection tubes
  33. Effects of lipemia on osmolality in native lipemic material and intravenous lipid emulsion added sera
  34. Does creatinine analytical performance support robust identification of acute kidney injury within individual laboratories in a region
  35. High serum amylase levels may reflect a wide spectrum of health benefits
  36. Optimal cut-off concentration for a faecal immunochemical test for haemoglobin by Hemo Techt NS-Plus C15 system for the colorectal cancer screening
  37. MTHFR C677T allelic variant is not associated with plasma and cerebrospinal fluid homocysteine in amyotrophic lateral sclerosis
  38. Analytical assessment of bone serum markers in patients suffering from spina bifida
  39. Serum concentrations and urinary excretion of homogentisic acid and tyrosine in normal subjects
Downloaded on 8.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2014-0540/html
Scroll to top button